Company Filing History:
Years Active: 2019-2023
Title: The Innovative Contributions of Hassan Javanbakh
Introduction
Hassan Javanbakh is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the treatment of viral disorders. With a total of 3 patents to his name, Javanbakh's work is paving the way for advancements in medical treatments.
Latest Patents
One of Javanbakh's latest patents focuses on oligomers and oligomer conjugates. This invention relates to an oligomer conjugate designed for the treatment of a viral disorder. The oligomer conjugate comprises an oligomer capable of modulating a target sequence in HBx and/or HBsAg of the Hepatitis B Virus (HBV). Additionally, it includes a carrier component that delivers the oligomer to the liver, which is linked, preferably conjugated, to the oligomer. This innovative approach has the potential to significantly impact the treatment of Hepatitis B.
Career Highlights
Hassan Javanbakh is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization allows him to collaborate with other talented professionals in the field.
Collaborations
Some of Javanbakh's notable coworkers include Søren Ottosen and Morten Lindow. Their combined expertise contributes to the innovative environment at Hoffmann-La Roche Inc.
Conclusion
Hassan Javanbakh's contributions to the field of biotechnology, particularly through his patents related to viral disorders, highlight his role as an influential inventor. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in healthcare.